Glioblastoma multiforme (GBM) is the most common form of primary malignant brain tumour, and yet its management is still largely unsuccessful compared with other cancers. This e-learning course discusses the selection of appropriate clinical endpoints and the challenges and opportunities associated with the use of specific measures, including neuroimaging and biomarkers in GBM.